Dr Boghuma Titanji and Dr Jade Ghosn at CROI 2023. Photo by Roger Pebody.When the mpox (monkeypox) virus began rapidly spreading to non-endemic countries in 2022, smallpox vaccines were widely recommended not only as post-exposure prophylaxis to minimise symptoms of the illness, but also to prevent infection. At the time, however, few data existed in humans to predict how effective a vaccine designed for smallpox would fare against its sister orthopoxvirus, mpox.
At the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle, researchers from France and the United States presented separate findings that add to the data on how effective smallpox vaccines are at preventing mpox infections.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
ECDC launches new monthly mpox surveillance report as transmission continues in Europe
-
NDTV: Mpox can infect and replicate in the brain, NIH researchers say in fatal HIV case
-
[Press release] University of Barcelona: People with HIV did not show more severe clinical symptoms during the 2022 mpox outbreak in Spain
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.